AnalystBook Research · Company Intelligence

Aeluma, Inc.

ALMUNasdaq

Built from Aeluma, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Aeluma revenue rose to $4.7M and losses narrowed, but insider selling was heavy and Beneish flagged caution.

The read at a glance✓ Audited against SEC data
  • Business mix — Compound semiconductor sensing platformNote
  • Revenue — Revenue rose to $4.7MOK
  • Cash — Free cash flow improved to -$1.3MNote
  • Margins — Gross margin improved to 59.61%OK
  • Balance sheet — Equity improved to $17.9MOK
  • Insiders — 0 buys / 40 sellsWatch
  • Accounting — Altman-Z safe; Beneish flagWatch

Business

Aeluma develops high-performance semiconductors for sensing, communication, and computing applications using compound semiconductor materials on large-diameter substrates.

Where the revenue comes from

Fiscal 2025, as Aeluma, Inc. reports it. History and quarterly detail are in the app.

  • Product and service, other$13.8M
  • Government Contracts$4.4M

Leadership changes

From Aeluma, Inc.'s own filings, the day they're filed.

  • Christopher Stewart · Chief Financial Officer · appointment
  • Michael Byron · President · departure

Latest filings

  • DEF 14A · Annual proxy (pay & governance)2026-09-30
  • 8-K · Company announcement2026-09-30
  • 8-K · Company announcement2026-09-16
  • 10-K · Annual report2026-09-16
  • 8-K · Company announcement2026-07-30
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Aeluma, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.